Diagnosis and treatment of hepatitis B virus infection complicated by metabolic syndrome / 临床肝胆病杂志

ABSTRACT

With the prevalence of obesity around the world, the incidence rate of hepatitis B virus (HBV) infection complicated by metabolic syndrome (MS) is increasing year by year, and such patients have become a special population in patients with chronic HBV infection. In recent years, the research on the features of this disease and diagnosis and treatment strategies has become a hot topic in the field of liver disease. MS not only increases the risk of liver fibrosis and cirrhosis in chronic hepatitis B (CHB) patients, but also reduces the response to antiviral therapy. Therefore, as for patients with HBV infection, especially CHB patients with suboptimal response to antiviral therapy, MS and its components should be considered. Screening and monitoring of liver cirrhosis should be performed for patients with HBV infection complicated by MS to guide the development of proper treatment regimens.